Spotlight on Union Bank: RBI’s Fine Fuels Fresh Debate on Banking Governance

Updated: May 09, 2025 19:06

Image Source: Studycafe

Union Bank of India has come under regulatory fire as the Reserve Bank of India (RBI) imposed a monetary penalty of ₹1.06 crore for significant lapses in compliance with central banking norms. The penalty, announced in an RBI order dated August 6, 2024, highlights the regulator’s ongoing crackdown on governance and risk management across the banking sector.

Key Highlights:

Nature of Violation: The RBI found Union Bank of India in breach of its directions on the ‘Creation of a Central Repository of Large Common Exposures-Across Banks’ and ‘Know Your Customer (KYC)’ norms. Specifically, the bank failed to ensure data accuracy and integrity in its CRILC (Central Repository of Information on Large Credits) reporting and did not carry out proper risk categorization for certain customers.
Inspection and Findings: The breaches were uncovered during the RBI’s Statutory Inspection for Supervisory Evaluation (ISE 2022), which reviewed the bank’s financials as of March 31, 2022. Following the inspection, the RBI issued a show-cause notice to the bank, and after considering the bank’s responses and oral submissions, decided the violations warranted a monetary penalty.
Regulatory Context: The RBI clarified that the penalty is based on deficiencies in statutory and regulatory compliance and is not a judgment on the validity of any customer transactions or agreements. The action is intended to reinforce the importance of robust compliance systems and accurate reporting in the banking sector.
Sector-Wide Action: Union Bank was among several financial institutions penalized in the same period for various regulatory lapses, underscoring the RBI’s heightened vigilance on governance and risk controls across the industry.

The penalty serves as a stern reminder to all banks about the critical importance of compliance and data integrity in India’s evolving financial landscape.

Sources: LexSite, CNBC TV18, Economic Times, The Hindu Business Line

Stay Ahead – Explore Now! Glenmark's Game-Changing Move: Epinephrine Injection Launch Injects New Life into US Portfolio